news

Dr Reddy’s recalls four lots of Phytonadione injectable emulsion in US

3
SHARES

The FDA has announced that Dr Reddy’s is recalling Phytonadione injectable emulsion because of complaints due to ampules breaking and shattering.

Syringe in injectable emulsion

The US Food and Drug Administration (FDA) has announced that Dr Reddy’s Laboratories is voluntarily recalling four lots of its Phytonadione injectable emulsion USP, 10 mg/mL, single-dose ampules to the hospital level.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

The product is being recalled because of complaints of ampules breaking and shattering, upon opening, during compounding.

According to the FDA, the company has received reports of cuts in skin and lacerations to health care professionals. There may be a reasonable probability that flying glass injuring skin, eye and/or other parts could result in either temporary or permanent injury.

The four lots being recalled are: ACB902, ACB903, ACB904 and ACB905. The batches were distributed nationwide in the US, between June 2019 and February 2020, to wholesalers, distributors, hospitals and pharmacies.

Phytonadione injectable emulsion is indicated for certain coagulation disorders including prophylaxis and therapy of hemorrhagic disease of the newborn and hypoprothrombinemia due to antibacterial therapy.

Dr Reddy’s Laboratories has also notified its distributors to arrange for return of any recalled product. Wholesalers, distributors, hospitals and pharmacies with an existing inventory of the lot being recalled should stop use and distribution of the product as well as quarantine the product immediately for return or replacement of all recalled products. 

More information about the recall can be found here

Share via
Share via